The Clinical Cancer Letter Archive
April 2008, Vol. 31 No. 4
AACR Annual Meeting: New Drugs, Older Drugs In New Uses, Show Progress Against Several Cancers. Preventing Colon Adenomas: APC Trial's Five-Year Results; DFMO Plus Sulindac May Be Effective. EPOC Trial Finds FOLFOX4 Improves PFS In Colon Cancer. SGO Meeting: BRCA Status Can Help Guide Treatment For Ovarian Cancer.
To download, subscribe to the newsletter or sign up for a one day pass.
March 2008, Vol. 31 No. 3
Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use. BMI A Potential Prognostic Tool For Breast Cancer. Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy. Gastric Cancer: Adjuvant Chemotherapy Didn't Improve Survival In Randomized Trial. Risks Of Long-Term HRT Outweigh Benefits, WHI Followup Finds. Researchers Find Cause Of Allergic Reaction To Cetuximab.
To download, subscribe to the newsletter or sign up for a one day pass.
February 2008, Vol. 31 No. 2
Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer. GI Cancer Symposium: Most Older Men With Early Prostate Cancer Can Avoid Treatment. Cancer Risk Reduction From Ovary Removal Varies By BRCA Type. Larynx Preservation Provides Better Voice Quality. PET Better Than CT At Response Evaluation In Sarcoma.
To download, subscribe to the newsletter or sign up for a one day pass.
January 2008, Vol. 31 No. 1
Early, Short Course Of Hormonal Therapy May Allow Prostate Cancer Patients To Live Longer. High-Dose Chemo, Stem Cell Transplant No Benefit For Node Positive Breast Cancer. Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer. Longterm Followup Finds Taxotere Improves Survival. Drug Combo Tested For Brain Metastasis. Multiple Myeloma: Rev/Vel/Dex Achieves High Response Rate In Early Clinical Trial.
To download, subscribe to the newsletter or sign up for a one day pass.
December 2007, Vol. 30 No. 12
American Society of Hematology Meeting: Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML. Phase III Results For Genasense. Evidence Links ESAs With Leukemic Transformation. JNCI: Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds.
To download, subscribe to the newsletter or sign up for a one day pass.
November 2007, Vol. 30 No. 11
ASCO Expanding Tools To Improve Coordination Of Cancer Treatment; Issues Several Clinical Guidelines. PET Three Months After Cervical Cancer Therapy Provides Early Warning Of Need For Intervention. Nexavar Approved For Inoperable Liver Cancer. Erbitux Improves Survival In Phase III Trial. Revlimid Plus Steroid Effective In Multiple Myeloma.
To download, subscribe to the newsletter or sign up for a one day pass.
October 2007, Vol. 30 No. 10
Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting. FDA Approvals: Ixempra For Metastatic Breast Cancer Resistant To Other Therapy; Erbitux Label Updated; Hycamtin For Relapsed SCLC. Trial Combines Drugs Against Blood Vessel Formations in Kidney Cancer.
To download, subscribe to the newsletter or sign up for a one day pass.
September 2007, Vol. 30 No. 9
Finasteride Raises Odds Of Finding Fast-Growing Cancers Early, Study Says. Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women. Black Women More Likely To Have Aggressive Tumors. Sexual Function Affected By Stem Cell Transplant.
To download, subscribe to the newsletter or sign up for a one day pass.
August 2007, Vol. 30 No. 8
Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction, SWOG Study Finds. Outcome Of Prostate Cancer Surgery Depends On Experience Of Surgeon, Study Says. Obesity An Indicator For Risk Of Developing Multiple Myeloma. NCI-Approved Cooperative Group, Cancer Center Trials Listed.
To download, subscribe to the newsletter or sign up for a one day pass.
July 2007, Vol. 30 No. 7
Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research. Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds. Breast Cancer Prediction Improved In Atypia Cases. Adding Arsenic Improves APL Survival. Bevacizumab Improves PFS In Advanced Kidney Cancer. NCI-Approved Trials Listed.
To download, subscribe to the newsletter or sign up for a one day pass.
June 2007, Vol. 30 No. 6
Oral Therapy Sorafenib Improves Survival of Advanced Liver Cancer. Fewer, Larger RT Doses Reduce Recurrence of Early Breast Cancer, UK Study Finds. Chemo Plus Surgery Cuts Risk of Liver Mets In Colon Cancer. MRI More Accurate Than Mammograms In Finding High Grade DCIS. New Approaches for Difficult Lung, Head & Neck Cancers Presented at ASCO. NCI-approved cooperative group trials listed.
To download, subscribe to the newsletter or sign up for a one day pass.
May 2007, Vol. 30 No. 5
ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma. Low Dose Therapy Improves Survival of Myeloma, ECOG, SWOG Find; Updates To Be Presented At ASCO. Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia. Sarcoma Survivors At High Risk Of Blood Clots, NCI Study Finds. GOG Longterm Results Find Cisplatin Therapies for Cervical Cancer Improve Overall Survival.
To download, subscribe to the newsletter or sign up for a one day pass.